Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples